世界の免疫調節剤市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Immunomodulators Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:94
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、免疫調節剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。免疫調節剤の種類別市場規模(免疫抑制剤、免疫賦活剤)、用途別市場規模(腫瘍、呼吸器、HIV、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Roche、Amgen Inc.、Abbott、Johnson & Johnson、Novartis AG、Eli Lilly and Company、Bristol-Myers Squibb Company、Merck & Co. Inc.、Biogen
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:免疫抑制剤、免疫賦活剤
・用途別分析2016年-2026年:腫瘍、呼吸器、HIV、その他
・免疫調節剤の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・免疫調節剤のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・免疫調節剤のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・免疫調節剤の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・免疫調節剤の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Immunomodulators market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Immunomodulators size is estimated to be xx million in 2021 from USD 140580 million in 2020, with a change of XX% between 2020 and 2021. The global Immunomodulators market size is expected to grow at a CAGR of 2.9% for the next five years.

Market segmentation
Immunomodulators market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Immunosuppressant
Immunostimulants

Market segment by Application can be divided into
Oncology
Respiratory
HIV
Others

The key market players for global Immunomodulators market are listed below:
Roche
Amgen Inc.
Abbott
Johnson & Johnson
Novartis AG
Eli Lilly and Company
Bristol-Myers Squibb Company
Merck & Co. Inc.
Biogen

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Immunomodulators product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Immunomodulators, with price, sales, revenue and global market share of Immunomodulators from 2019 to 2021.
Chapter 3, the Immunomodulators competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunomodulators breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Immunomodulators market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Immunomodulators sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Immunomodulators Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immunomodulators Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Immunosuppressant
1.2.3 Immunostimulants
1.3 Market Analysis by Application
1.3.1 Overview: Global Immunomodulators Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Respiratory
1.3.4 HIV
1.3.5 Others
1.4 Global Immunomodulators Market Size & Forecast
1.4.1 Global Immunomodulators Sales in Value (2016-2026))
1.4.2 Global Immunomodulators Sales in Volume (2016-2026)
1.4.3 Global Immunomodulators Price by Type (2016-2026) & (USD/Unit)
1.5 Global Immunomodulators Production Capacity Analysis
1.5.1 Global Immunomodulators Total Production Capacity (2016-2026)
1.5.2 Global Immunomodulators Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Immunomodulators Market Drivers
1.6.2 Immunomodulators Market Restraints
1.6.3 Immunomodulators Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Immunomodulators Product and Services
2.1.4 Roche Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Amgen Inc.
2.2.1 Amgen Inc. Details
2.2.2 Amgen Inc. Major Business
2.2.3 Amgen Inc. Immunomodulators Product and Services
2.2.4 Amgen Inc. Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Immunomodulators Product and Services
2.3.4 Abbott Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Immunomodulators Product and Services
2.4.4 Johnson & Johnson Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Immunomodulators Product and Services
2.5.4 Novartis AG Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business
2.6.3 Eli Lilly and Company Immunomodulators Product and Services
2.6.4 Eli Lilly and Company Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Bristol-Myers Squibb Company
2.7.1 Bristol-Myers Squibb Company Details
2.7.2 Bristol-Myers Squibb Company Major Business
2.7.3 Bristol-Myers Squibb Company Immunomodulators Product and Services
2.7.4 Bristol-Myers Squibb Company Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Merck & Co. Inc.
2.8.1 Merck & Co. Inc. Details
2.8.2 Merck & Co. Inc. Major Business
2.8.3 Merck & Co. Inc. Immunomodulators Product and Services
2.8.4 Merck & Co. Inc. Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Biogen
2.9.1 Biogen Details
2.9.2 Biogen Major Business
2.9.3 Biogen Immunomodulators Product and Services
2.9.4 Biogen Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Immunomodulators Sales by Manufacturer
3.1 Global Immunomodulators Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Immunomodulators Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Immunomodulators
3.4 Market Concentration Rate
3.4.1 Top 3 Immunomodulators Manufacturer Market Share
3.4.2 Top 6 Immunomodulators Manufacturer Market Share
3.5 Global Immunomodulators Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Immunomodulators Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Immunomodulators Market Size by Region
4.1.1 Global Immunomodulators Sales in Volume by Region (2016-2026)
4.1.2 Global Immunomodulators Revenue by Region (2016-2026)
4.2 North America Immunomodulators Revenue (2016-2026)
4.3 Europe Immunomodulators Revenue (2016-2026)
4.4 Asia-Pacific Immunomodulators Revenue (2016-2026)
4.5 South America Immunomodulators Revenue (2016-2026)
4.6 Middle East and Africa Immunomodulators Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Immunomodulators Sales in Volume by Type (2016-2026)
5.2 Global Immunomodulators Revenue by Type (2016-2026)
5.3 Global Immunomodulators Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Immunomodulators Sales in Volume by Application (2016-2026)
6.2 Global Immunomodulators Revenue by Application (2016-2026)
6.3 Global Immunomodulators Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Immunomodulators Sales by Type (2016-2026)
7.2 North America Immunomodulators Sales by Application (2016-2026)
7.3 North America Immunomodulators Market Size by Country
7.3.1 North America Immunomodulators Sales in Volume by Country (2016-2026)
7.3.2 North America Immunomodulators Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Immunomodulators Sales by Type (2016-2026)
8.2 Europe Immunomodulators Sales by Application (2016-2026)
8.3 Europe Immunomodulators Market Size by Country
8.3.1 Europe Immunomodulators Sales in Volume by Country (2016-2026)
8.3.2 Europe Immunomodulators Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Immunomodulators Sales by Type (2016-2026)
9.2 Asia-Pacific Immunomodulators Sales by Application (2016-2026)
9.3 Asia-Pacific Immunomodulators Market Size by Region
9.3.1 Asia-Pacific Immunomodulators Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Immunomodulators Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Immunomodulators Sales by Type (2016-2026)
10.2 South America Immunomodulators Sales by Application (2016-2026)
10.3 South America Immunomodulators Market Size by Country
10.3.1 South America Immunomodulators Sales in Volume by Country (2016-2026)
10.3.2 South America Immunomodulators Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Immunomodulators Sales by Type (2016-2026)
11.2 Middle East & Africa Immunomodulators Sales by Application (2016-2026)
11.3 Middle East & Africa Immunomodulators Market Size by Country
11.3.1 Middle East & Africa Immunomodulators Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Immunomodulators Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Immunomodulators Typical Distributors
12.3 Immunomodulators Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

...

【掲載企業】

Roche、Amgen Inc.、Abbott、Johnson & Johnson、Novartis AG、Eli Lilly and Company、Bristol-Myers Squibb Company、Merck & Co. Inc.、Biogen

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の免疫調節剤市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Immunomodulators Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。